Home » Topics » BioWorld Science

BioWorld Science
RSS

NO-donating NSAIDs may attenuate neuroinflammation in Alzheimer's disease

Aug. 5, 2004

YM-348 reduces food intake, body weight gain in obesity model

Aug. 4, 2004

Abbott submits NDA for Zemplar capsules

Aug. 4, 2004

Epzicom receives FDA approval

Aug. 4, 2004

Lipitor approved to reduce risk of heart attacks

Aug. 4, 2004

OSI completes Tarceva NDA filing in NSCLC

Aug. 4, 2004

Accelerated approval for Truvada

Aug. 4, 2004

Antituberculosis agent shows promising effects in pilot trial

Aug. 4, 2004

mondoBIOTECH and Bachem sign aviptadil agreement

Aug. 4, 2004

R-112 reduces symptoms of allergic rhinitis in phase II study

Aug. 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...